Background Dual antiplatelet therapy (DAPT) cessation increases the risk of adverse events
after percutaneous coronary intervention (PCI). Whether risk changes over time, depends …

Background Myocardial injury is frequent among patients hospitalized with coronavirus
disease-2019 (COVID-19) and is associated with a poor prognosis. However, the mechanisms of …

Background Whether the direct factor Xa inhibitor rivaroxaban can prevent thromboembolic
events after transcatheter aortic-valve replacement (TAVR) is unclear. Methods We randomly …

Rotational atherectomy facilitates percutaneous coronary intervention for complex de novo
lesions with severe calcification. A strategy of routine rotational atherectomy has not, however…

Objectives : This study sought to determine the impact of short-term intensive statin therapy
on intracoronary plaque lipid content. Background : Statin therapy significantly reduces the …

Background : The Absorb everolimus-eluting poly-L-lactic acid–based bioresorbable vascular
scaffold (BVS) provides early drug delivery and mechanical support functions similar to …

Background In patients with coronary artery disease who receive metallic drug-eluting
coronary stents, adverse events such as late target-lesion failure may be related in part to the …

Background : Dual-antiplatelet therapy with aspirin and clopidogrel after percutaneous
coronary intervention reduces the risk for coronary thrombotic events (CTEs) at the expense of …

Background : The optimal duration of dual antiplatelet therapy (DAPT) after drug-eluting
stent (DES) implantation is unclear, and its risks and benefits may vary according to DES …

Since optical coherence tomography (OCT) was first performed in humans two decades ago,
this imaging modality has been widely adopted in research on coronary atherosclerosis …